论文部分内容阅读
1964年,人们就认识到巨细胞病毒(CMV)是肾移植患者的主要致病原。本文作者通过口服acyclovir(简称A)与安慰剂(简称D)来研究预防肾移植患者并发cmv 性疾病中A 的作用。
In 1964, it was recognized that cytomegalovirus (CMV) is the major causative agent of kidney transplant recipients. The authors study the role of A in the prevention of concurrent CMV disease in renal transplant recipients by oral administration of acyclovir (abbreviated A) and placebo (abbreviated as D).